Author

W.S. Kim

Observed names: W. S. Kim, Woo Jung Kim

Institution: Sungkyunkwan University

Observed institutions: Samsung Medical Center, Sungkyunkwan University

OpenAlex ID: A5089893041

EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?

2014 · J.Y. Hong, D.H. Yoon, et al. · Annals of Oncology · 71

Polatuzumab Vedotin Plus Bendamustine and Rituximab or Obinutuzumab in Relapsed/refractory Fl or Dlbcl: Updated Results of a Phase 1b/2 Study

2017 · M. Matasar, A.F. Herrera, et al. · Hematological Oncology · 9

Managing Cytokine Release Syndrome (crs) and Neurotoxicity With Step‐up Dosing of Mosunetuzumab in Relapsed/refractory (r/r) B‐cell Non‐hodgkin Lymphoma (nhl)

2019 · L.H. Sehn, S. Assouline, et al. · Hematological Oncology · 3

Exploratory Biomarker Analysis in the Ph 3 Echelon‐1 Study: Worse Outcome With Abvd in Patients With Elevated Baseline Levels of Scd30 and Tarc

2019 · J. Radford, J.M. Connors, et al. · Hematological Oncology · 1

PCN26 Health State Utilities for Relapsed/Refractory (Rel/Ref) Hodgkin'S Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL): Asian Pacific Country Data

2012 · P. Swinburn, S.L. Shingler, et al. · Value in Health · 1

Classification and Analysis of Safety Variables for Post-Authorisation Safety Studies of Advanced Therapy Medicinal Products

2026 · Jiu Kim, Eunby Na, et al. · Journal of Pharmacoepidemiology and Risk Management

Regulatory and Case Analysis of Long-Term Follow-Up for Advanced Therapy Medicinal Products Based on the European Medicines Agency Post-Authorisation Safety Study

2026 · Jiu Kim, Eunby Na, et al. · Journal of Pharmacoepidemiology and Risk Management

330MO Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B cell malignancies

2023 · J. Zhu, J. Li, et al. · Annals of Oncology

Ps1094 Managing Cytokine Release Syndrome (crs) and Neurotoxicity With Step‐fractionated Dosing of Mosunetuzumab in Relapsed/refractory (r/r) B‐cell Non‐hodgkin Lymphoma (nhl)

2019 · S.‐S. Yoon, M. Matasar, et al. · HemaSphere

Safety Analysis of Patients With a Medical History of Respiratory Disorders Treated With Copanlisib From the Chronos‐1 Study in Relapsed or Refractory Indolent B‐cell Lymphoma

2019 · P.L. Zinzani, A. Santoro, et al. · Hematological Oncology

Treatment of Extranodal Nk/t‐cell Lymphoma, Nasal Type (enktl)

2017 · W.S. Kim · Hematological Oncology

Improved Survival Outcomes for Patients With Extra‐nodal Nk/t Lymphoma: Data From 140 Patients Prospectively Registered in the International T‐cell Project

2017 · C.P. Fox, M. Bellei, et al. · Hematological Oncology

306 * Clinical Outcomes of Sliding Tracheoplasty in Congenital Tracheal Stenosis

2013 · S. Chung, J. Yang, et al. · Interactive Cardiovascular and Thoracic Surgery

Works count: 13

Citation count: 85

H-index: 3

I10-index: 1